SERODIA -Chagas is an in-vitro diagnostic test kit for the detection of antibodies to Trypanosoma cruzi in human serum/plasma. This test is based on Fujirebio's particle-agglutination assay using gel
The Cellabs T. cruzi IgG CELISA is a direct ELISA kit designed to detect antibodies produced during T. cruzi infections (Chagas disease).
Inquire
Silicone ICD lead
Medicine Products:(Date:7/18/2008)...istance to chemotherapy drugs, sometimes abruptly,...ing well to reduce tumors or hold them in check? ...lt when this occurs is all too familiar: patients ...ecome resistant. , A team of researchers at Cold...stand the genetic underpinnings of cancer therapy ...
(Date:7/18/2008)...swire/ -- Baxa Corporation, a,Denver-based manufac...,handling, packaging, and administering medicatio...site for health-system users of its software and,p...wn as eBUG for,electronic Baxa Users, Group, offer...ting a virtual ,community, for sharing pharmacy be...
(Date:7/18/2008)...wswire-USNewswire/ -- William S.,Harris, Ph.D., FA...ter,dated July 16:, Eating fish, especially oily...heart disease prevention. Fish is low in total and...ce minerals, and contains,long-chain omega-3 fatty...thy omega-3s include salmon, trout, albacore tuna,...
(Date:7/18/2008)...- Standing Tall announced today that,two-time Tony...e Peters has,joined its Board of Directors., "Sta...e in the area,that supports the most severely dis... "The children at Standing Tall gain mobility and ...rn to walk and talk as they also learn,reading, ma...
Breaking Medicine News(10 mins):Health News:CSHL scientists correlate enzyme expression levels with chemotherapy drug response 2Health News:CSHL scientists correlate enzyme expression levels with chemotherapy drug response 3Health News:CSHL scientists correlate enzyme expression levels with chemotherapy drug response 4Health News:Baxa Corporation Launches New Electronic Users' Group Web Site 2Health News:An Open Letter Regarding Recent Reports That Low-Fat Fish Like Tilapia Are Unhealthy (July 16, 2008) 2Health News:An Open Letter Regarding Recent Reports That Low-Fat Fish Like Tilapia Are Unhealthy (July 16, 2008) 3Health News:Bernadette Peters Joins Board of Directors of Standing Tall, Innovative Program for Multiply Disabled Children 2Better prostate cancer detection,
Prevention is better than cure
...h has shown that folate supplements, widely recomm...he chances of having twins. Professor Judith Lumle...e supplement trials and found women who took folat...ad a 50 per cent greater chance of having twins.//...
... in the retinal vein could not only make you loose...o blocked veins is so painful that the eye may hav...rsity California have devised a new instrument tha...bullets of blockage-dissolving drugs into a clogge...
Other Medicine News:Health News:Blocked viens block eye sight 2(Date:7/17/2008)...ire/ -- Impliant, Inc., a developer of,novel spine...y announced,that it conducted the first surgery in...f its TOPS(TM) System, a Total Posterior,Arthropla...or without facet,arthrosis and spondylolisthesis. ...urosurgeon at the Charlotte Neurosurgery and Spine...
(Date:7/17/2008)...pares favorably to data from other, technologies ...all/ - Bradmer Pharmaceuticals Inc.,(TSX: BMR), a ...ment and,commercialization of cancer therapies, to...from two previously conducted Phase II trials of,N...ents. As an exploratory,endpoint of the single arm...
(Date:7/16/2008)...ire/ -- In the clinical phase I trial,AFF001, AFFi...ts planned,for this trial. The trial aims to inves...e Alzheimer,s vaccine (AFFITOPE AD01). In the tria...once and have so far tolerated,the vaccine extreme...ons,administered at monthly intervals and is due t...
(Date:7/16/2008)...RNewswire-FirstCall/ -- MAP,Pharmaceuticals, Inc. ...ts,from a Phase 2 study evaluating the safety, tol... asthmatics were published in the July,issue of Cu...icals is,developing MAP0004, an orally inhaled and...nt for migraine., The study results, which were f...
Breaking Medicine Technology:Impliant Launches Less-Invasive Version of Patented TOPS(TM) Spine System 2Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 2Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 3Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 4Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials 5AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer's Vaccine 2AFFiRiS: Milestone Reached in Clinical Trial of Alzheimer's Vaccine 3MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 2MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 3MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion 4Neighborhoods play key role in how much people exercise study says 14519 1Neighborhoods play key role in how much people exercise study says 14519 2Neighborhoods play key role in how much people exercise study says 14519 3BUs School of Law Public Health to hold conference on the future of health law 14516 1BUs School of Law Public Health to hold conference on the future of health law 14516 2DRAXIS Responds to Trading 14512 1DRAXIS Responds to Trading 14512 2DRAXIS Responds to Trading 14512 3DRAXIS Responds to Trading 14512 4Frying Tumors Can Boost Lung Cancer Survival 14509 1Frying Tumors Can Boost Lung Cancer Survival 14509 2Frying Tumors Can Boost Lung Cancer Survival 14509 3...atically reduce the risk of cancer returning,after... tumors,(GIST), EAST HANOVER, N.J., April 12, 2007... Gleevec(R) (imatinib mesylate)* tablets to,patien...nical trial,after an interim analysis showed parti... tumors treated with Gleevec following,surgery wer...
... 2007 /PRNewswire-FirstCall/ - AEterna,Zentaris In...,focused on endocrine therapy and oncology, today ...ning first in vitro data on its,PI3K inhibitors as...132, which both may potentially provide new therap...e abstracts will be,presented at the American Asso...
Other Medicine Technology:Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 2Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 3Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 4Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 5Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 6Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 7AEterna Zentaris To Present First In Vitro Data for PI3K Inhibitors,and In Vivo Results for a GHRH Antagonist at the AACR Annual,Meeting in Los Angeles 2AEterna Zentaris To Present First In Vitro Data for PI3K Inhibitors,and In Vivo Results for a GHRH Antagonist at the AACR Annual,Meeting in Los Angeles 3